BioCentury
ARTICLE | Management Tracks

Longtime Alkermes CEO Pops to hand baton to COO Jackson; Sarepta CEO to depart at year-end

BioCentury’s latest management moves in biopharma

February 26, 2026 1:51 AM UTC

After 35 years leading Alkermes, Richard Pops will hand off the CEO role to his COO while remaining chairman.

Pops became CEO of the company in 1991 at age 29, when Alkermes plc (NASDAQ:ALKS) was a private biotech of 25 employees focused on drug delivery. Under his leadership, the company now has multiple approved drugs and a market cap north of $5 billion. ...